nilotinib monohydrochloride monohydrate and its Impurities

Nilotinib Monohydrochloride Monohydrate is used to treat Philadelphia chromosome positive chronic myelogenous leukaemia. It is sold under the brand name Tasigna. It is not safe for use during pregnancy. Reference standards of Nilotinib Monohydrochloride Monohydrate API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 5 results for nilotinib monohydrochloride monohydrate Impurities
PA 14 85000

Nilotinib Monohydrochloride Monohydrate

Nilotinib Monohydrochloride Monohydrate

  • Catalogue No.:PA 14 85000

  • CAS :

    923288-90-8

  • Molecular Formula : C28H25ClF3N7O2

  • Molecular Weight : 583.99

Enquire
Details
PA 14 85040

Nilotinib Monohydrochloride Monohydrate - Impurity D

4-Methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]benzoic Acid

  • Catalogue No.:PA 14 85040

  • CAS :

    641569-94-0

  • Molecular Formula : C17H14N4O2

  • Molecular Weight : 306.33

Enquire
Details
PA 14 85050

Nilotinib Monohydrochloride Monohydrate - Impurity E

N-[3-(1H-Imidazol-1-yl)-5-(trifluoromethyl)phenyl]-4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]benzamide

  • Catalogue No.:PA 14 85050

  • CAS :

    2119583-26-3

  • Molecular Formula : C27H20F3N7O

  • Molecular Weight : 515.50

Enquire
Details
PA 14 85060

Nilotinib Monohydrochloride Monohydrate - Impurity F

N-(3-(4-Ethyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzamide

  • Catalogue No.:PA 14 85060

  • CAS :

    2119583-24-1

  • Molecular Formula : C29H24F3N7O

  • Molecular Weight : 543.55

Enquire
Details
PA 14 85070

Nilotinib Monohydrochloride Monohydrate - Impurity G

Methyl 4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoate

  • Catalogue No.:PA 14 85070

  • CAS :

    917392-54-2

  • Molecular Formula : C18H16N4O2

  • Molecular Weight : 320.35

Enquire
Details
Periodic Table- Pharmaffiliates

Calculators
Periodic Table- Pharmaffiliates

Contact us

Ask A Scientist-Pharmaffiliates

Ask a Scientist
General Help

General Help
CPHI INDIA- 28, 30 November